Skip Navigation


Annals of Oncology Advance Access originally published online on May 26, 2005
Annals of Oncology 2005 16(9):1551-1555; doi:10.1093/annonc/mdi266
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
16/9/1551    most recent
mdi266v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Randi, G.
Right arrow Articles by La Vecchia, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Randi, G.
Right arrow Articles by La Vecchia, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

History of cirrhosis and risk of digestive tract neoplasms

G. Randi1,2,*, A. Altieri1, S. Gallus1, S. Franceschi2, E. Negri1, R. Talamini3 and C. La Vecchia1,4

1 Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy; 2 International Agency for Research on Cancer, Lyon, France; 3 Servizio di Epidemiologia, Centro di Riferimento Oncologico, Aviano (PN), Italy; 4 Istituto di Statistica Medica e Biometria, Università degli Studi di Milano, Milan, Italy

* Correspondence to: Dr G. Randi, Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Eritrea 62, 20157 Milan, Italy. Tel: 0039-02-39 014-541; Fax: 0039-332 00 231; Email: randi{at}marionegri.it

Background: Cirrhosis is strongly related to liver cancer. Data on the possible association between cirrhosis and risk at other cancer sites are scanty.

Patients and methods: We analysed data from a network of case–control studies conducted in Italy between 1983 and 1997, including patients with cancers of the oral cavity and pharynx (520), oesophagus (405), stomach (731), colon (943), rectum (613), liver (425), gallbladder (63) and pancreas (395). The controls were 4297 patients admitted to hospitals for acute non-neoplastic conditions.

Results: After strict allowance for alcohol drinking, tobacco smoking and history of hepatitis, the multivariate odds ratios for a history of cirrhosis were 4.7 [95% confidence interval (CI) 2.2–9.8] for neoplasms of the oral cavity and pharynx, 2.6 (95% CI 1.2–5.7) for the oesophagus, 1.0 (95% CI 0.4–2.5) for the stomach, 1.0 (95% CI 0.4–2.4) for the colon, 1.7 (95% CI 0.7–4.1) for the rectum, 20.5 (95% CI 12.3–34.2) for the liver, 2.1 (95% CI 0.3–16.8) for the gallbladder and 0.9 (95% CI 0.3–3.0) for the pancreas.

Conclusions: Our study confirms and further quantifies the increased risk of liver cancer in cirrhotic patients and is compatible with an increased risk of oral, pharyngeal and oesophageal cancers.

Key words: cancer, cirrhosis, digestive tract, risk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.